Description

AMP-CV 625 is a broad-spectrum beta-lactam antibiotic combination containing Amoxycillin and Potassium Clavulanate. It is designed to overcome beta-lactamase–producing bacterial resistance.

Amoxycillin inhibits bacterial cell wall synthesis, leading to cell lysis and death. Potassium Clavulanate is a beta-lactamase inhibitor that protects Amoxycillin from enzymatic degradation, thereby restoring its activity against resistant strains.

This combination provides effective coverage against Gram-positive, Gram-negative, and anaerobic organisms. It is widely used in respiratory, urinary, skin, soft tissue, and dental infections.

Composition

Each film-coated tablet contains:
Amoxycillin Trihydrate IP (equivalent to Amoxycillin 500 mg)
Potassium Clavulanate Diluted IP (equivalent to Clavulanic Acid 125 mg)
Excipients – q.s.

Indications

• Upper & lower respiratory tract infections

• Urinary tract infections

• Skin & soft tissue infections

• ENT infections

• Dental infections

• Bone & joint infections

Dosage

As directed by the physician.

Storage

Store below 25°C in a dry place.
Protect from moisture.
Keep out of reach of children.

Presentation

10 x 10 Tablets (Alu-Alu Blister)